This reference page presents Relative Strength Index forecast data for Dyne Therapeutics. The model output shown here is derived from Dyne Therapeutics's historical price series and is provided for informational purposes.
This Relative Strength Index forecast data for Dyne Therapeutics is sourced from the most recent available trading data and is intended solely as reference information.
Relative Strength Index Analysis Today
Dyne Therapeutics has current Relative Strength Index of 49.28.
On March 22 2026 Dyne Therapeutics was traded for 17.56 at the closing time. Highest Dyne Therapeutics's price during the trading hours was 18.84 and the lowest price during the day was 17.25 . There was no trading activity during the period. Lack of trading volume on the 22nd of March did not affect price variability. The overall trading delta to current price is 1.82% .
For every potential investor in Dyne, whether a beginner or expert, Dyne Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better.
The following equities are related to Dyne Therapeutics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Dyne Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
Market strength indicators help investors to evaluate how Dyne Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dyne Therapeutics shares will generate the highest return on.
The analysis of Dyne Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Dyne Therapeutics' investment and either accepting that risk or mitigating it.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Dyne Therapeutics
Coverage intensity for Dyne Therapeutics matters because narrative visibility can influence sentiment, participation, and volatility around the name. This is most useful when investors want to understand why a security is suddenly drawing more public discussion.
Short sentiment tied to Dyne Therapeutics matters because heavier bearish pressure can change how quickly future price expectations become unstable. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
Common Stock Shares Outstanding
128.4 M
Cash And Short Term Investments
1.1 B
More Resources for Dyne Stock Analysis
Understanding Dyne Therapeutics starts with reviewing its financial statements and long-term patterns. Ratios reflect how the business performs across profit and resource use. These values are derived from Dyne Therapeutics' published financial data. Selected reports below provide context for Dyne Stock:
